Literature DB >> 1353217

Prediction of outcome in fulminant hepatic failure by serum human hepatocyte growth factor.

H Tsubouchi, S Kawakami, S Hirono, H Miyazaki, M Kimoto, T Arima, K Sekiyama, M Yoshiba, N Arakaki, Y Daikuhara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1353217     DOI： 10.1016/0140-6736(92)92396-w

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

Review 1.  Bone marrow cell-based regenerative therapy for liver cirrhosis.

Authors:  Takafumi Saito; Kyoko Tomita; Hiroaki Haga; Kazuo Okumoto; Yoshiyuki Ueno
Journal:  World J Methodol       Date:  2013-12-26

2.  Characteristics of rat bone marrow cells differentiated into a liver cell lineage and dynamics of the transplanted cells in the injured liver.

Authors:  Kazuo Okumoto; Takafumi Saito; Hiroaki Haga; Etsuko Hattori; Rika Ishii; Tetsuru Karasawa; Akihiko Suzuki; Keiko Misawa; Mai Sanjo; Jun-itsu Ito; Kazuhiko Sugahara; Koji Saito; Hitoshi Togashi; Sumio Kawata
Journal:  J Gastroenterol       Date:  2006-01       Impact factor: 7.527

3.  Treatment for accidental occlusion of the hepatic artery after hepatic resection: report of two cases.

Authors:  G Tanabe; K Kawaida; M Hamanoue; K Kihara; S Hirata; M Maemura; S Ueno; T Aikou
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

4.  Clinical impact of serum transforming growth factor-alpha mRNA as a predictive biomarker for the prognosis of fulminant hepatitis.

Authors:  Norimasa Miura; Hiroko Kabashima; Mika Shimizu; Reina Sato; Tomoe Tsukamoto; Tomomi Harada; Shunsaku Takahashi; Ryujin Endo; Nobuaki Nakayama; Yasuhiro Takikawa; Satoshi Mochida; Kazuyuki Suzuki; Junichi Hasegawa; Goshi Shiota
Journal:  Hepatol Int       Date:  2008-04-09       Impact factor: 6.047

5.  Serum hepatocyte growth factor as an index of extensive catabolism of patients awaiting liver transplantation.

Authors:  C Miki; A D Mayer; J A Buckels; K Iriyama; H Suzuki; P McMaster
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

6.  Hepatitis A complicated with acute renal failure and high hepatocyte growth factor: A case report.

Authors:  Shinji Oe; Michihiko Shibata; Koichiro Miyagawa; Yuichi Honma; Masaaki Hiura; Shintaro Abe; Masaru Harada
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

7.  Safety and pharmacokinetics of recombinant human hepatocyte growth factor (rh-HGF) in patients with fulminant hepatitis: a phase I/II clinical trial, following preclinical studies to ensure safety.

Authors:  Akio Ido; Akihiro Moriuchi; Masatsugu Numata; Toshinori Murayama; Satoshi Teramukai; Hiroyuki Marusawa; Naohisa Yamaji; Hitoshi Setoyama; Il-Deok Kim; Tsutomu Chiba; Shuji Higuchi; Masayuki Yokode; Masanori Fukushima; Akira Shimizu; Hirohito Tsubouchi
Journal:  J Transl Med       Date:  2011-05-08       Impact factor: 5.531

8.  Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease.

Authors:  Timo Rath; Lisa Hage; Marion Kügler; Katrin Menendez Menendez; Reinhart Zachoval; Lutz Naehrlich; Richard Schulz; Martin Roderfeld; Elke Roeb
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

9.  Clinical outcomes and healthcare utilization of acute hepatitis A virus infection with acute kidney injury in hospitalized patients.

Authors:  Ahmad Khan; Khadija Sami; Adnan Malik; Muhammad Mujtaba Bhinder; Khadija Naseem; Kamesh Gupta; Arsalan Siddiqui; Emad Mansoor; Shailendra Singh; Khalid Mumtaz
Journal:  Eur J Gastroenterol Hepatol       Date:  2021-12-01       Impact factor: 2.586
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.